Conference
Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels
Authors
Shipley WU; Hunt D; Lukka H; Major P; Heney NM; Grignon D; Patel M; Bahary J; Lawton C; Sandler H
Volume
78
Publisher
Elsevier
Publication Date
January 1, 2010
DOI
10.1016/j.ijrobp.2010.07.103
Conference proceedings
International Journal of Radiation Oncology • Biology • Physics
Issue
3
ISSN
0360-3016